The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Protein and Nucleotide Biosynthesis Are Coupled by a Single Rate-Limiting Enzyme, PRPS2, to Drive Cancer
Open accessAbstract
Cancer cells must integrate multiple biosynthetic demands to drive indefinite proliferation. How these key cellular processes, such as metabolism and protein synthesis, crosstalk to fuel cancer cell growth is unknown. Here, we uncover the mechanism by which the Myc oncogene coordinates the production of the two most abundant classes of cellular macromolecules, proteins, and nucleic acids in cancer cells. We find that a single rate-limiting enzyme, phosphoribosyl-pyrophosphate synthetase 2 (PRPS2), promotes increased nucleotide biosynthesis in Myc-transformed cells. Remarkably, Prps2 couples protein and nucleotide biosynthesis through a specialized cis-regulatory element within the Prps2 5' UTR, which is controlled by the oncogene and translation initiation factor eIF4E downstream Myc activation. We demonstrate with a Prps2 knockout mouse that the nexus between protein and nucleotide biosynthesis controlled by PRPS2 is crucial for Myc-driven tumorigenesis. Together, these studies identify a translationally anchored anabolic circuit critical for cancer cell survival and an unexpected vulnerability for "undruggable" oncogenes, such as Myc. PAPERFLICK:
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among the c-myc-regulated targets are phosphoribosyl pyrophosphate synthetase 2 (PRPS2), which catalyzes a first step of purine biosynthesis, as well as carbamoyl phosphate synthetase II (CAD), which initiates the pyrimidine ring-building cascade (Cunningham et al., 2014; Eberhardy and Farnham, 2001; Mannava et al., 2008).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Cunningham et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Hwang, T., & Shaka, A. J. (1995) · Journal of Magnetic Resonance Series A · doi:10.1006/jmra.1995.1047 · Cited by 1,929
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
Dieterle, F., Ross, A., Schlotterbeck, G., & Senn, H. (2006) · Analytical Chemistry · doi:10.1021/ac051632c · Cited by 1,772
The translational landscape of mTOR signalling steers cancer initiation and metastasis
Hsieh, A. C., Liu, Y., Edlind, M. P., Ingolia, N. T., Janes, M. R., Sher, A., Shi, E. Y., Stumpf, C. R., Christensen, C., Bonham, M. J., et al. (2012) · Nature · doi:10.1038/nature10912 · Cited by 1,313
Self-citationMetabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC‐1α
Gerhart‐Hines, Z., Rodgers, J. T., Bare, O., Lerin, C., Kim, S., Mostoslavsky, R., Alt, F. W., Wu, Z., & Puigserver, P. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601633 · Cited by 1,294
AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
Faubert, B., Boily, G., Izreig, S., Griss, T., Samborska, B., Dong, Z., Dupuy, F., Chambers, C., Fuerth, B. J., Viollet, B., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.001 · Cited by 949
Cited by
Sorted by citations
Items 101–200 of 260
Pei, W., Xu, L., Varshney, G. K., Carrington, B., Bishop, K. S., Jones, M., Huang, S. C., Idol, J., Pretorius, P. R., Beirl, A. J., et al. (2016) · Scientific Reports · doi:10.1038/srep29946 · Cited by 36
MYC, Metabolic Synthetic Lethality, and Cancer
Hsieh, A. L., & Dang, C. V. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42118-6_4 · Cited by 38
Goetting, I., Jendrossek, V., & Matschke, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228563 · Cited by 37
Transcription Factor AP4 Mediates Cell Fate Decisions: To Divide, Age, or Die
Wong, M. M.-K., Joyson, S. M., Hermeking, H., & Chiu, S. K. (2021) · Cancers · doi:10.3390/cancers13040676 · Cited by 36
Regulatory T cells suppress CD4+ effector T cell activation by controlling protein synthesis
So, L., Obata‐Ninomiya, K., Hu, A. K., MUIR, V. S., Takamori, A., Song, J., Buckner, J. H., Savan, R., & Ziegler, S. F. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20221676 · Cited by 40
Crosstalks between translation and metabolism in cancer
Biffo, S., Manfrini, N., & Ricciardi, S. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.10.011 · Cited by 36
Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC–Driven Cancer Progression
Gao, J., Jung, M., Mayoh, C., Venkat, P., Hannan, K. M., Fletcher, J. I., Kamili, A., Gifford, A. J., Kusnadi, E. P., Pearson, R. B., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3914 · Cited by 34
Pan, H., Hu, Q., Wang, J., Liu, Z., Wu, D., Lü, W., & Huang, J. Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.158 · Cited by 33
Agarwal, S., Chakravarthi, B. V. S. K., Kim, H., Gupta, N., Hale, K., Balasubramanya, S. A. H., Oliver, P. G., Thomas, D. G., Eltoum, I. A., Buchsbaum, D. J., et al. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100776 · Cited by 32
Filamentation modulates allosteric regulation of PRPS
Hu, H.-H., Lu, G., Chang, C., Li, Y., Zhong, J., Guo, C.-J., Zhou, X., Yin, B., Zhang, T., & Liu, J. (2022) · eLife · doi:10.7554/elife.79552 · Cited by 30
Curti, L., Rohban, S., Bianchi, N., Croci, O., Andronache, A., Barozzi, S., Mattioli, M., Ricci, F., Pastori, E., Sberna, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51229-5 · Cited by 33
Emergence of a geometric pattern of cell fates from tissue-scale mechanics in the Drosophila eye
Gallagher, K. D., Mani, M., & Carthew, R. W. (2022) · eLife · doi:10.7554/elife.72806 · Cited by 30
Premature polyadenylation of MAGI3 produces a dominantly-acting oncogene in human breast cancer
Ni, T. K., & Kuperwasser, C. (2016) · eLife · doi:10.7554/elife.14730 · Cited by 31
Fine-tuned amplification in cells
Dang, C. V. (2014) · Nature · doi:10.1038/nature13518 · Cited by 29
Lei, B., Wan, B., Peng, J. W., Yang, Y., Lv, D., Zhou, X., Shu, F., Li, F., Zhong, L., Wu, H., et al. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.04.116 · Cited by 28
Profiling of subcellular EGFR interactome reveals hnRNP A3 modulates nuclear EGFR localization
Wang, T., Wu, C., Huang, K., Chuang, W., Hsueh, C., Li, H., & Chen, C. (2020) · Oncogenesis · doi:10.1038/s41389-020-0225-0 · Cited by 27
Rogava, M., Aprati, T. J., Chi, W.-Y., Melms, J. C., Hug, C. B., Davis, S. H., Earlie, E. M., Chung, C., Deshmukh, S. K., Wu, S. K., et al. (2024) · Nature Cancer · doi:10.1038/s43018-023-00704-x · Cited by 27
Spz/Toll-6 signal guides organotropic metastasis in Drosophila
Mishra-Gorur, K., Li, D., Ma, X., Yarman, Y., Xue, L., & Xu, T. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039727 · Cited by 26
Critical roles and clinical perspectives of RNA methylation in cancer
Li, G., Yao, Q., Liu, P., Zhang, H., Liu, Y., Li, S., Shi, Y., Li, Z., & Zhu, W. (2024) · MedComm · doi:10.1002/mco2.559 · Cited by 29
Non-Hodgkin Lymphoma Metabolism
Kirsch, B. J., Chang, S., & Le, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77736-8_7 · Cited by 26
Chai, R., Wang, N., Chang, Y., Zhang, K., Li, J., Niu, J.-J., Wu, F., Liu, Y., & Wang, Y. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0867-1 · Cited by 25
Is there a CDKN2A-centric network in pancreatic ductal adenocarcinoma?
Wu, C. L., Yang, P., Liu, B., & Tang, Y. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s232464 · Cited by 29
Antihyperuricemic Effect of Urolithin A in Cultured Hepatocytes and Model Mice
Adachi, S.-I., Sasaki, K., Kondo, S., Komatsu, W., Yoshizawa, F., Isoda, H., & Yagasaki, K. (2020) · Molecules · doi:10.3390/molecules25215136 · Cited by 24
ATIC facilitates cell growth and migration by upregulating Myc expression in lung adenocarcinoma
Niu, N., Zeng, J., Ke, X., Zheng, W., Fu, C., Lv, S., Fu, J., & Yu, Y. (2022) · Oncology Letters · doi:10.3892/ol.2022.13251 · Cited by 25
c-Myc plays a key role in IFN-γ-induced persistence of Chlamydia trachomatis
Vollmuth, N., Schlicker, L., Guo, Y., Hovhannisyan, P., Janaki‐Raman, S., Kurmasheva, N., Schmitz, W., Schulze, A., Stelzner, K., Rajeeve, K., et al. (2022) · eLife · doi:10.7554/elife.76721 · Cited by 29
FOXK2 affects cancer cell response to chemotherapy by promoting nucleotide de novo synthesis
Li, Y., Chen, J., Wang, B., Xu, Z., Wu, C., Ma, J., Song, Q., Geng, Q., Yu, J., Pei, H., et al. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100926 · Cited by 24
MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast Cancer
Meena, J. K., Wang, J. H., Neill, N. J., Keough, D. T., Putluri, N., Katsonis, P., Koire, A. M., Lee, H., Bowling, E. A., Tyagi, S., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0649 · Cited by 26
Qiao, H., Tan, X., Lv, D., Xing, R., Shu, F., Zhong, C., Li, C., Zou, Y.-G., & Mao, X. (2019) · Journal of Cancer · doi:10.7150/jca.37401 · Cited by 23
Cencioni, C., Scagnoli, F., Spallotta, F., Nasi, S., & Illi, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044217 · Cited by 28
On-demand utilization of phosphoribosyl pyrophosphate by downstream anabolic pathways
Pinson, B., Moenner, M., Saint‐Marc, C., Granger‐Farbos, A., & Daignan‐Fornier, B. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105011 · Cited by 23
Kim, H. (2019) · Biomolecules · doi:10.3390/biom9110665 · Cited by 24
Rahmatpanah, F. B., Robles, G. D., Lilly, M. B., Keane, T. E., Kumar, V., Mercola, D., Randhawa, P., & McClelland, M. (2021) · Oncotarget · doi:10.18632/oncotarget.28024 · Cited by 22
Liu, G., Luo, Y., & Hou, P. (2021) · Immunological Investigations · doi:10.1080/08820139.2021.1952217 · Cited by 22
SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPAT
Huo, F., Xie, M., Zhu, Z., Zheng, J., & Pei, D. (2022) · Genomics · doi:10.1016/j.ygeno.2022.110424 · Cited by 21
PRPS1 silencing reverses cisplatin resistance in human breast cancer cells
He, M., Chao, L., & You, Y.-P. (2016) · Biochemistry and Cell Biology · doi:10.1139/bcb-2016-0106 · Cited by 21
Iorio, P. D., Ronci, M., Giuliani, P., Caciagli, F., Ciccarelli, R., Caruso, V., Beggiato, S., & Zuccarini, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010262 · Cited by 21
Han, S., Basting, P. J., Dias, G. B., Luhur, A., Zelhof, A. C., & Bergman, C. (2021) · Genetics · doi:10.1093/genetics/iyab113 · Cited by 19
Ugbogu, E. A., Schweizer, L. M., & Schweizer, M. (2022) · Cells · doi:10.3390/cells11121909 · Cited by 28
Maharjan, A., Singhvi, M. S., Kafle, S. R., & Kim, B. S. (2023) · Process Biochemistry · doi:10.1016/j.procbio.2023.07.002 · Cited by 20
Miao, W., & Wang, Y. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00119 · Cited by 20
NOTCH1-driven UBR7 stimulates nucleotide biosynthesis to promote T cell acute lymphoblastic leukemia
Srivastava, S., Sahu, U., Zhou, Y., Hogan, A., Sathyan, K. M., Bodner, J., Huang, J., Wong, K. A., Khalatyan, N., Savas, J. N., et al. (2021) · Science Advances · doi:10.1126/sciadv.abc9781 · Cited by 19
Structural basis of human PRPS2 filaments
Lu, G., Hu, H.-H., Chang, C., Zhong, J., Zhou, X., Guo, C.-J., Zhang, T., Li, Y., Yin, B., & Liu, J. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01037-z · Cited by 19
Control of Nucleotide Metabolism Enables Mutant p53’s Oncogenic Gain-of-Function Activity
Schmidt, V. A., Nagar, R., & Martinez, L. A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122759 · Cited by 20
Zhang, L., Zhao, X., Hu, J., Li, T., Chen, H., Zhang, A., Wang, H., Yu, J., & Zhang, L. (2025) · Nature Communications · doi:10.1038/s41467-025-59119-0 · Cited by 18
Urea cycle dysregulation: a new frontier in cancer metabolism and immune evasion
Shou, Y., Liu, R., Xiong, H., Xu, K., Chen, X., Huang, L., Zhang, Y., Sheng, H., Zhang, H., & Lü, Y. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02328-3 · Cited by 19
Fernandez, B., Passanisi, V. J., Ashraf, H. M., & Spencer, S. L. (2025) · Nature Communications · doi:10.1038/s41467-025-66836-z · Cited by 18
Mao, X., Shu, F., Lei, B., Xie, L., Zhang, S., Wan, B., Zhong, L., & Zhou, X. (2019) · Asian Journal of Andrology · doi:10.4103/aja.aja_122_19 · Cited by 18
Li, J., Ye, J., Zhu, S., & Cui, H. (2019) · Cells · doi:10.3390/cells8090955 · Cited by 18
Avdulov, S. V., Herrera, J., Smith, K. A., Peterson, M., Gómez-García, J. R., Beadnell, T. C., Schwertfeger, K. L., Benyumov, A. O., Manivel, J. C., Li, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2571 · Cited by 17
Interplay between mTOR and Purine Metabolism Enzymes and Its Relevant Role in Cancer
Allegrini, S., Camici, M., Garcia‐Gil, M., Pesi, R., & Tozzi, M. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126735 · Cited by 17
Zirin, J. D., Ni, X., Sack, L. M., Yang‐Zhou, D., Hu, Y., Brathwaite, R., Bulyk, M. L., Elledge, S. J., & Perrimon, N. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821863116 · Cited by 17
N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma
Kuzuoğlu‐Öztürk, D., Aksoy, O., Schmidt, C., Lea, R., Larson, J. D., Phelps, R. R. L., Nasholm, N. M., Holt, M., Contreras, A., Huang, M., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0945 · Cited by 13
Kimoloi, S. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.027 · Cited by 15
Alfaifi, A., Bahashwan, S., Alsaadi, M., Malhan, H. M., Aqeel, A., Al-Kahiry, W., Almehdar, H. A., & Qadri, I. (2022) · Diagnostics · doi:10.3390/diagnostics12020394 · Cited by 17
New targeted therapies for malignant lymphoma based on molecular heterogeneity
Horn, H., Staiger, A. M., & Ott, G. (2016) · Expert Review of Hematology · doi:10.1080/17474086.2017.1268046 · Cited by 15
Oncogenic kinases and perturbations in protein synthesis machinery and energetics in neoplasia
Uchenunu, O., Pollak, M., Topisirović, I., & Hulea, L. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0058 · Cited by 16
Non-Hodgkin Lymphoma Metabolism
Kirsch, B. J., Chang, S., Betenbaugh, M. J., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_7 · Cited by 17
A shift in glutamine nitrogen metabolism contributes to the malignant progression of cancer
Kodama, M., Oshikawa, K., Shimizu, H., Yoshioka, S., Takahashi, M., Izumi, Y., Bamba, T., Tateishi, C., Tomonaga, T., Matsumoto, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15136-9 · Cited by 14
PRPS1-mediated purine biosynthesis is critical for pluripotent stem cell survival and stemness
Yang, Y., Song, L., Huang, X., Feng, Y., Zhang, Y., Liu, Y., Li, S., Zhan, Z., Zheng, L., Feng, H., et al. (2021) · Aging · doi:10.18632/aging.202372 · Cited by 14
Kasprzyk, R., Starek, B. J., Ciechanowicz, S., Kubacka, D., Kowalska, J., & Jemielity, J. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201900051 · Cited by 14
Chromosomal instability causes sensitivity to protein folding stress and ATP depletion
Khan, M., Shaukat, Z., Saint, R. B., & Gregory, S. L. (2018) · Biology Open · doi:10.1242/bio.038000 · Cited by 13
Role of PRPS2 as a prognostic and therapeutic target in osteosarcoma
Luo, Y., Yuan, J., Huang, J., Yang, T., Zhou, J., Juan, T., Liu, M., Chen, J., Chen, C., Huang, W., et al. (2021) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-206505 · Cited by 12
The Metabolic Relationship Between Viral Infection and Cancer
Mullen, P. J., & Christofk, H. R. (2021) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-070120-090423 · Cited by 14
Liu, W., Zha, W., Yin, H., Yang, C., Lu, K., & Chen, J. (2023) · Chemical Engineering and Processing - Process Intensification · doi:10.1016/j.cep.2023.109306 · Cited by 12
An, F., Zhang, Z., Xia, M., & XING, L. (2015) · Oncology Reports · doi:10.3892/or.2015.4150 · Cited by 12
Skare, Ø., Lie, R. T., Haaland, Ø. A., Gjerdevik, M., Romanowska, J., Gjessing, H. K., & Jugessur, A. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00025 · Cited by 10
Molecular mechanism of c‐Myc and PRPS1/2 against thiopurine resistance in Burkitt's lymphoma
Li, T., Song, L., Zhang, Y., Han, Y., Zhan, Z., Xv, Z., Li, Y., Yang, Y., Wang, S., wang, S., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15322 · Cited by 11
The oncogenic control of nucleotide synthesis
Vidal-Cruchez, O., & Ben‐Sahra, I. (2026) · Oncogenesis · doi:10.1038/s41389-026-00608-2 · Cited by 11
Targeting pivotal amino acids metabolism for treatment of leukemia
Hong, J., Liu, W., Xiao, X., Gajendran, B., & Ben‐David, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40492 · Cited by 10
Prps1l1, a testis‐specific gene, is dispensable for mouse spermatogenesis
Wang, Z., Lee, S., Oliver, D., Yuan, S., Tang, C., Wang, Y., Zheng, H., & Yan, W. (2018) · Molecular Reproduction and Development · doi:10.1002/mrd.23053 · Cited by 10
Dai, H., Xu, X., Li, W., Fu, X., Han, W., & Li, G. (2023) · Molecules · doi:10.3390/molecules28135141 · Cited by 10
Chakravorty, D., Jana, T., Mandal, S. D., Seth, A., Bhattacharya, A., & Saha, S. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1652-6 · Cited by 10
Le, Y., Shen, X., Kang, H., Wang, Q., Li, K., Zheng, J., & Yu, Y. (2017) · Journal of Mass Spectrometry · doi:10.1002/jms.4048 · Cited by 10
Li, F., Wang, Q., Xiong, X., Wang, C., Liu, X., Liao, Z., Li, K., Xie, B., & Lin, Y. (2018) · Cancer Management and Research · doi:10.2147/cmar.s158547 · Cited by 10
(TORC)ing up purine biosynthesis
Ma, E. H., & Jones, R. G. (2016) · Science · doi:10.1126/science.aaf1929 · Cited by 10
Viral Reprogramming of Nucleotide Synthesis and Its Impact on Viral Infection
Dsouza, L., & Yang, Z. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70563 · Cited by 9
Karki, B. R., MacMillan, A. C., Vicente-Muñoz, S., Greis, K. D., Romick, L. E., & Cunningham, J. T. (2025) · Nature Communications · doi:10.1038/s41467-025-61216-z · Cited by 11
Strefeler, A., Baker, Z. N., Chollet, S., Foged, M. M., Guerra, R. M., Ivanišević, J., Gallart‐Ayala, H., Pagliarini, D. J., & Jourdain, A. A. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01419-2 · Cited by 17
Santos, K. D., Kim, M., Yergeau, C., Jean, S., & Moon, N.-S. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008376 · Cited by 8
RetractedNRF2-directed PRPS1 upregulation to promote the progression and metastasis of melanoma
Xiong, G., Feng, Y., Yi, X., Zhang, X., Li, X., Yang, L., Yi, Z., Sai, B., Yang, Z., Zhang, Q., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.989263 · Cited by 8
PRPS activity tunes redox homeostasis in Myc-driven lymphoma
MacMillan, A. C., Karki, B., Yang, J., Gertz, K. R., Zumwalde, S., Patel, J. A., Czyzyk-Krzeska, M., Meller, J., & Cunningham, J. T. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103649 · Cited by 8
Proteomic analysis enables distinction of early‐ versus advanced‐stage lung adenocarcinomas
Kelemen, O., Plá, I., Sánchez, A., Rezeli, M., Szász, A. M., Malm, J., László, V., Kwon, H. J., Döme, B., & Marko‐Varga, G. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.106 · Cited by 8
Zhang, X., Zhang, D., Fan, A., Zhou, X., Yang, C., Zhou, J., Shen, M., Liu, H., Zou, K., & Tao, J. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.09.020 · Cited by 7
Exploiting Translation Machinery for Cancer Therapy: Translation Factors as Promising Targets
Sehrawat, U. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910835 · Cited by 8
MLCK inhibition induces synthetic lethality in MYC-driven cancer
Sun, Z., Wu, R., Liang, X., Shi, T., Zhang, Y., Pan, Z., Zhang, W., & Luan, X. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217803 · Cited by 8
Jamerson, L. E., & Bradshaw, P. C. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.09.001 · Cited by 7
Wojtowicz, E. E., Hampton, K., Moreno‐Gonzalez, M., Utting, C., Lan, Y., Ruiz, P. S. B., Beasy, G., Bone, C., Hellmich, C., Maynard, R. S., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06932-w · Cited by 8
Metabolic control of cancer progression as novel targets for therapy
Talukdar, S., Emdad, L., Gogna, R., Das, S. K., & Fisher, P. B. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.06.002 · Cited by 6
Chu, Q., Gu, X., Zheng, Q., Wang, J., & Zhu, H. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s340758 · Cited by 6
Zhong, W., Ma, L., Yang, F., Cao, J., Tan, J., & Li, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1027441 · Cited by 6
Liu, Q., Wu, N., & Hou, P. (2024) · Thoracic Cancer · doi:10.1111/1759-7714.15398 · Cited by 5
Song, L., Li, P., Sun, H., Ding, L., Wang, J., Li, B., Zhou, B. S., Feng, H., & Li, Y. (2022) · Blood Science · doi:10.1097/bs9.0000000000000139 · Cited by 6
Uridine-sensitized screening identifies genes and metabolic regulators of nucleotide synthesisPreprint
Strefeler, A., Baker, Z. N., Chollet, S., Guerra, R. M., Ivanišević, J., Gallart‐Ayala, H., Pagliarini, D. J., & Jourdain, A. A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.11.642569 · Cited by 6
Mittal, S., Nenwani, M., Kadamberi, I. P., Kumar, S., Animasahun, O. H., George, J., Tsaih, S., Gupta, P., Singh, M., Geethadevi, A., et al. (2025) · Advanced Science · doi:10.1002/advs.202506307 · Cited by 5
Adapting Drosophila melanogaster Cell Lines to Serum-Free Culture Conditions
Luhur, A., Mariyappa, D., Klueg, K. M., Buddika, K., Tennessen, J. M., & Zelhof, A. C. (2020) · G3 Genes Genomes Genetics · doi:10.1534/g3.120.401769 · Cited by 5
Ji, S., Liu, Y., Xu, Y., Gao, J., Jin, J., Jiang, P., Li, Y. K., Su, D., Zhao, Y., Yang, S., et al. (2026) · Nature Microbiology · doi:10.1038/s41564-026-02326-2 · Cited by 4
Vera-Chang, M. N., Danforth, J. M., Stuart, M., Goodarzi, A. A., Brand, M., & Richardson, R. B. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01564-z · Cited by 4
Dimitriou, I. D., Meiri, D., Jitkova, Y., Elford, A. R., Koritzinsky, M., Schimmer, A. D., Ohashi, P. S., Sonenberg, N., & Rottapel, R. K. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2101090 · Cited by 4
Chen, C., Su, T., Morselli, M., & Kurdistani, S. K. (2025) · Cancer & Metabolism · doi:10.1186/s40170-025-00399-x · Cited by 5
PRPS-Associated Disorders and the Drosophila Model of Arts Syndrome
Santos, K. D., Kwon, E., & Moon, N.-S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144824 · Cited by 4
Metadata
- Authors
- Cunningham, J. T., Moreno, M. V., Lodi, A., Ronen, S. M., & Ruggero, D.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Ruggero, Davide
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 157
- Issue
- 5
- Pages
- 1088-1103
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4140650
- OpenAlex
- W2073120856
- Cited by
- 260
- References
- 57
- Citations by year
- 2026: 20 · 2025: 18 · 2024: 30 · 2023: 17 · 2022: 24 · 2021: 24 · 2020: 20 · 2019: 23 · 2018: 13 · 2017: 16 · 2016: 25 · 2015: 23 · 2014: 7
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Update notices
- erratum (2014-07-31)
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Leukemia and Lymphoma Society
- Gladstone Institutes
- Regeneron Pharmaceuticals
- National Institutes of Health
- University of California, Davis
- National Human Genome Research Institute (U01HG004085, U01HG004080)
- National Cancer Institute (R01 CA130812, R01CA140456, R01CA154915, R01CA154916)
- National Center for Research Resources (U42RR024244)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- PRPS2, phosphoribosylpyrophosphate synthetase, MYC oncogene, nucleotide synthesis, protein synthesis, rate-limiting enzyme, eIF4E, translation initiation, anabolic metabolism, carcinogenesis, tumor cell proliferation
- MeSH terms
- Animals, B-Lymphocytes, Base Sequence, Burkitt Lymphoma, Cells, Cultured, Humans, Isoenzymes, Molecular Sequence Data, Nucleotides, Ribose-Phosphate Pyrophosphokinase, Protein Biosynthesis, Proto-Oncogene Proteins c-myc, Mice, Knockout, 5' Untranslated Regions, Eukaryotic Initiation Factor-4E, NIH 3T3 Cells, Cell Line, Tumor, Mice, Embryonic Stem Cells, Gene Knockdown Techniques, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review